Scientists should realize that if they submit to journals — like those published by Elsevier, Springer, Kluwer, Wiley and the like — then their work will be less accessible and not as widely read as it would be if it was published in an Open Access journal.
Current Biology is published by Elsevier (who are also involved in the arms trade), which means that Ashburner is pushing for Open Access publishing in a non-Open Access journal. Good stuff.
Ashburner’s advocacy of Open Access publishing should come as no surprise, as he is a vocal proponent of open access to genomic data. He also walks the walk — he will only publish in journals that are Open Access. I’ve said it before, and I’ll say it again: I’m glad I’ve got Ashburner on my team.